Episode Details
Back to Episodes
Deals, Dupixent and GLP-1 drug shortages
Published 2 years, 7 months ago
Description
This week we talk struggles with GLP-1 drug shortages and what that might mean for Novo/Lilly competitors; Regeneron and Sanofi positive results for Dupixent in COPD.
Plus, Merck buys Caraway, Beigene's deal with Ensem, ups and downs for Flagship.
Join BioSpace's Lori Ellis, Greg Slabodkin and Tyler Patchen as they discuss the most important biopharma news this week.